Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 13,124 shares at $30.60 ($399K) on 2023-09-12, disclosed to the SEC on 2023-09-13.
Open-market purchase of $399k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.30 | 4,687 | $142K | 35.6% |
| 2 | $30.30 | 4,687 | $142K | 35.6% |
| 3 | $30.60 | 3,750 | $115K | 28.8% |
| Total | $30.39 avg | 13,124 | $399K | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |